# Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China

> **NCT05873426** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 6 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** [14C] ZSP1273

## Key facts

- **NCT ID:** NCT05873426
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-25
- **Primary completion:** 2023-04-28
- **Final completion:** 2023-04-28
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873426, "Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05873426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*